"OpenAI Considering Entry into Healthcare Sector with Personal Health Assistant and More"
"A Significant Number of ChatGPT Users Ask Medical-Related Questions"
OpenAI, the developer of ChatGPT, is reportedly considering entering the artificial intelligence (AI)-based healthcare market.
On November 10 (local time), U.S. business media outlet Business Insider reported, citing sources, that OpenAI is reviewing the development of consumer health tools, including a personal health assistant and health data aggregation services.
Previously, in June, OpenAI recruited Nate Gross, co-founder of the medical platform Doximity. Two months later, the company scouted Ashley Alexander, Vice President at Instagram, appointing her as Vice President in charge of health-related products.
Gross revealed at a digital healthcare expo last month that ChatGPT has 800 million weekly users, with a significant portion of them asking medical-related questions.
Industry experts point out that OpenAI would need to address regulatory issues before entering the medical field. Previously, companies such as Microsoft and Apple attempted to enter the healthcare sector but either abandoned their initiatives or scaled them back due to regulatory challenges. In fact, Verily, Google’s health technology subsidiary, was sued by a former executive for allegedly using patient health data without authorization and attempting to conceal it.
However, Business Insider predicted that, as governments have recently begun easing related regulations and more users are seeking to directly view and manage their health data through digital tools, OpenAI may collaborate with other healthcare companies to collect medical data.
Hot Picks Today
Record Results Expected, but SK hynix Weighs a "Split-Off Listing" Amid High Expectations
- "I Came to Korea and Easily Made 3.3 Million Won a Month"... The "Easy Gig" Everyone's Talking About Among International Students Turns Out to Be...
- President Lee's Approval Rating Falls 2.2 Percentage Points to 35.2% [The Asia Business Daily-Realmeter Poll]
- "Oh Eunyoung's Consultation Fee: Millions of Won? Not Expensive"... Yonsei Professor's Sharp Rebuke over "300,000-Won Lecture Fee"
- "To Charge Her Phone"... Woman Unplugs Freezer at Self-Service Store, Melting Ice Cream - What Happened?
Business Insider also noted, "OpenAI is already partnering with major pharmaceutical companies such as Eli Lilly and Sanofi for drug development, and is working with health tech firm Penda Health to develop an AI-based clinical decision support system."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
